EyePoint Pharmaceuticals ... (EYPT)

AI Score

Unlock

4.98

-0.39 (-7.26%)

At close: Apr 03, 2025, 3:59 PM

5.12

2.81%

After-hours: Apr 03, 2025, 07:33 PM EDT

EyePoint Pharmaceuticals Balance Sheet Statement

Chart Mode

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012	FY 2011	FY 2010	FY 2009	FY 2008	FY 2007	FY 2006	FY 2005	FY 2004	FY 2003	FY 2001
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Jun 30, 2018	Jun 30, 2017	Jun 30, 2016	Jun 30, 2015	Jun 30, 2014	Jun 30, 2013	Jun 30, 2012	Jun 30, 2011	Jun 30, 2010	Jun 30, 2009	Jun 30, 2008	Jun 30, 2007	Jun 30, 2006	Jun 30, 2005	Jun 30, 2004	Jun 30, 2003	Jun 30, 2001
Cash & Equivalents	99.7M	281.26M	95.63M	178.59M	44.91M	22.21M	38.78M	16.9M	15.31M	19.12M	15.33M	6.9M	4.63M	12.91M	15.51M	6.9M	15.61M	2.67M	11.47M	9.79M	21.79M	792.81K	1.64M
Short-Term Investments	271.21M	49.79M	48.93M	32.97M	n/a	n/a	n/a	n/a	13.68M	9.41M	2.94M	3.37M	9.95M	11.22M	2.05M	2.05M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	150K	150K	150K	150K	150K	150K	n/a	150K	150K	150K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	5.98M	n/a	1.36M	626K	150K	507K	150K	260K	264K	266K	267K	176K	77K	60K	60K	109K	819K	1K	n/a	n/a	22.68K	42.88K	1.00
Receivables	607K	805K	15.5M	18.35M	9.45M	11.37M	353K	353K	251K	488K	622K	517K	597K	967K	843K	1.11M	815K	1.47M	2.51M	743K	236.6K	68.79K	82.06K
Inventory	2.31M	3.91M	2.89M	3.62M	5.34M	2.14M	-353K	-251K	-488K	-622K	n/a	-597K	-967K	-843K	-1.11M	n/a	n/a	513K	469.37K	n/a	n/a	n/a	0.64
Other Current Assets	9.48M	1.01M	9.86M	4.22M	3.42M	n/a	1.13M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.00	626.00	n/a	n/a	6.46K
Total Current Assets	383.31M	344.8M	172.81M	237.75M	63.12M	42.07M	39.91M	17.74M	29.96M	29.84M	19.34M	12.46M	15.96M	25.37M	19.03M	8.13M	17.69M	5.69M	12.68M	10.57M	22.05M	879.68K	1.73M
Property-Plant & Equipment	29.18M	10.23M	6.04M	2.25M	3.24M	3.08M	253K	313K	290K	338K	297K	179K	335K	123K	43K	66K	473K	511K	2.33M	2.49M	465.37K	271.6K	379.78K
Goodwill & Intangibles	n/a	n/a	n/a	22.75M	25.21M	27.67M	31.36M	364K	1.1M	1.93M	2.77M	3.43M	4.23M	21.56M	23.88M	28.8M	36.8M	79.92M	159.84M	49.24M	5.51M	3.63M	2.61M
Total Long-Term Assets	35.16M	10.38M	7.55M	25.63M	28.6M	31.25M	31.76M	937K	1.66M	2.53M	3.33M	3.79M	4.64M	21.75M	23.98M	28.98M	38.09M	80.43M	162.17M	51.72M	6M	3.94M	2.99M
Total Assets	418.46M	355.18M	180.36M	263.37M	91.72M	73.32M	71.67M	18.68M	31.62M	32.37M	22.67M	16.25M	20.6M	47.11M	43.01M	37.1M	55.78M	86.12M	174.85M	62.3M	28.05M	4.82M	4.72M
Account Payables	11.72M	6.5M	5.92M	7.38M	4.81M	4.19M	2.64M	2.94M	1.02M	1.36M	744K	464K	671K	394K	328K	387K	284K	2.63M	7.54M	5.51M	1.53M	807.67K	n/a
Deferred Revenue	17.78M	38.59M	1.21M	1.07M	945K	15K	30K	50K	147K	33K	138K	738K	2.18M	3.21M	79K	5.91M	10.48M	1.7M	1.98M	2.67B	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	10.47M	n/a	n/a	481K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	8.33M	n/a	n/a	n/a
Other Current Liabilities	13.27M	5.54M	6.09M	5.58M	5.69M	3.09M	15M	-14.61M	2.59M	2.27M	1.84M	572K	642K	459K	170K	1.31M	971K	1.93M	8.12M	1.97M	22.69K	-732.61K	145.74K
Total Current Liabilities	49.05M	63.26M	34.54M	23.66M	14.89M	11.87M	21.66M	5.29M	5.09M	3.35M	2.13M	3.3M	3.18M	5.03M	2.93M	8.72M	17.28M	18.09M	17.79M	1.56M	1.35M	588.38K	145.74K
Long-Term Debt	21.86M	n/a	29.31M	36.56M	37.98M	47.22M	17.31M	17.31M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	145.74K
Other Long-Term Liabilities	11.06M	n/a	600K	2.35M	2.37M	3M	21.01M	-17.26M	51K	60K	55K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	2.93M	2.92M	n/a	n/a	-145.74K
Total Long-Term Liabilities	32.92M	25.6M	49.45M	55.33M	58.29M	53.12M	38.32M	51K	5.64M	5.65M	5.62M	5.25M	3.78M	4.65M	7.04M	4.84M	8.43M	2.13M	27.09M	1.49M	807.67K	362.97K	-0.29
Total Liabilities	81.96M	88.86M	83.99M	78.99M	73.18M	64.99M	59.98M	5.34M	10.74M	9M	7.75M	8.55M	6.96M	9.68M	9.97M	13.56M	25.71M	20.21M	44.89M	1.56M	1.35M	588.38K	145.74K
Total Debt	21.86M	4.91M	45.77M	38.42M	40.31M	50.6M	17.31M	17.31M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	11.26M	n/a	n/a	n/a	145.74K
Common Stock	68K	49K	766.93M	752.64M	528.38M	472.78M	374.84M	323.32M	312.24M	293.09M	29K	270.44M	264.45M	262.93M	250.81M	18K	18K	18K	n/a	81.93M	34.72M	10.48M	6.18M
Retained Earnings	-873.02M	-742.15M	-671.35M	-569.1M	-510.68M	-465.29M	-363.99M	-310.82M	-292.21M	-270.67M	-277.01M	-263.66M	-251.76M	-226.92M	-218.29M	-227.05M	-224.54M	-151.95M	-42.27M	-21.2M	-9.17M	-6.39M	-2.31M
Comprehensive Income	1.03M	864K	786K	841K	841K	840K	838K	833K	852K	945K	1.04M	920K	942K	1.43M	521K	2.07M	6.97M	10.91M	1.18M	15.77K	54.35K	158.00	n/a
Shareholders Equity	336.5M	266.32M	96.37M	184.38M	18.54M	8.33M	11.69M	13.34M	20.88M	23.37M	14.92M	7.7M	13.64M	37.43M	33.04M	23.54M	30.08M	65.91M	129.96M	60.74M	25.6M	4.09M	4.57M
Total Investments	271.21M	49.94M	48.93M	32.97M	150K	150K	150K	n/a	13.68M	9.41M	2.94M	3.37M	9.95M	11.22M	2.05M	2.05M	n/a	n/a	n/a	n/a	n/a	n/a	n/a